0000000000490953
AUTHOR
J Werner
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic
Association of Surgeons in Training Surgical Summit, online, 17 Oct 2020 - 17 Oct 2020 2021 Virtual Annual Meeting / Surgical Research Society, online, 24 Mar 2021 - 25 Mar 2021, National Research Collaborative Meeting, online, 10 Dec 2020 - 10 Dec 2020, Royal Australasian College of Surgeons Annual Academic Surgery Conference, online, 5 Nov 2020 - 5 Nov 2020; The British journal of surgery : BJS 108(12), 1448-1464 (2021). doi:10.1093/bjs/znab336
DETERMINATION OF ALPHA(S) FOR B-QUARKS AT THE Z(0) RESONANCE
The strong coupling constant for b quarks has been determined, and its flavour independence, as predicted by QCD, investigated. The analysis involved events with lepton candidates selected from approximately 356 000 hadronic decays of the Z0, collected by the DELPHI detector at LEP in 1990 and 199 1. A method based on a direct comparison of the three-jet fraction in a b enriched sample, selected by requiring leptons with large momenta and transverse momenta, to that of the entire hadronic sample, illustrated the significant effect of the b quark mass on the multi-jet cross section, and verified the flavour independence of the strong coupling constant to an accuracy of +/- 6%. A second proce…
DETERMINATION OF ALPHA-S FROM THE SCALING VIOLATION IN THE FRAGMENTATION FUNCTIONS IN E+E- ANNIHILATION
A determination of the hadronic fragmentation functions of the Z0 boson is presented from a study of the inclusive hadron production with the DELPHI detector at LEP. These fragmentation functions were compared with the ones at lower energies, thus covering data in a large kinematic range: 196 less-than-or-equal-to Q2 less-than-or-equal-to 8312 GeV2 and x (= p(h)/E(beam)) > 0.08. A large scaling violation was observed, which was used to extract the strong coupling constant in second order QCD: alpha(s)(M(Z)) = 0.118 +/- 0.005. The corresponding QCD scale for five quark flavours is: LAMBDA(MS)(5)BAR = 230 +/- 60 MeV.
Delaying surgery for patients with a previous SARS-CoV-2 infection
With at least 28 elective million operations delayed during the first three months of the COVID-19 pandemic, the number of patients who will require surgery after a previous SARS-CoV-2 infection is likely to increase rapidly1. Operating on patients with an active perioperative SARS-CoV-2 infection is now known to carry a very high pulmonary complication and mortality rate2. Urgent information is needed to guide whether postponing surgery in patients with a previous SARS-CoV-2 infection leads to a clinical benefit, and the optimal length of delay.
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
This international, prospective, cohort study enrolled 20 006 adult (≥18 years) patients from 466 hospitals in 61 countries with 15 cancer types, who had a decision for curative surgery during the COVID-19 pandemic and were followed up until the point of surgery or cessation of follow-up (Aug 31, 2020). Average national Oxford COVID-19 Stringency Index scores were calculated to define the government response to COVID-19 for each patient for the period they awaited surgery, and classified into light restrictions (index 60). The primary outcome was the non-operation rate (defined as the proportion of patients who did not undergo planned surgery). Cox proportional-hazards regression models wer…
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic.
Abstract Background Surgical services are preparing to scale up in areas affected by COVID-19. This study aimed to evaluate the association between preoperative SARS-CoV-2 testing and postoperative pulmonary complications in patients undergoing elective cancer surgery. Methods This international cohort study included adult patients undergoing elective surgery for cancer in areas affected by SARS-CoV-2 up to 19 April 2020. Patients suspected of SARS-CoV-2 infection before operation were excluded. The primary outcome measure was postoperative pulmonary complications at 30 days after surgery. Preoperative testing strategies were adjusted for confounding using mixed-effects models. Results Of 8…